GGFG-PAB-Exatecan TFA
GGFG-PAB-Exatecan TFA is a drug-linker conjugate designed for antibody-drug conjugate (ADC) synthesis, combining the potent topoisomerase I inhibitor Exatecan with a cleavable GGFG-PAB linker. This construct is utilized in research for developing targeted cancer therapies and has been evaluated in both in vitro and in vivo preclinical studies.
Product Specifications
Field of Research
Immunology & Inflammation; Pharmacology & Drug Discovery, Molecular Biology
Smiles
NCC (NCC (N[C@@H] (CC1=CC=CC=C1) C (NCC (NC (C=C2) =CC=C2COC (N[C@@H]3C4=C5C (C (N6C5) =CC ([C@] (O) (C (OC7) =O) CC) =C7C6=O) =NC8=CC (F) =C (C) C (CC3) =C84) =O) =O) =O) =O) =O.O=C (O) C (F) (F) F
Molecular Formula
C49H48F4N8O12
Molecular Weight
1016.95
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2462-100 1x 100 µL
Ki-67 (Proliferating Cell Marker) (MKI67/2462), 0.2mg/mL
Sign In for Pricing
View Details 
BNC470411-500 1x 500 µL
BCL-10 (BL10/411), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
